Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Neomycin recalled?

Yes — there is an active recall. 9 ongoing FDA recalls mention Neomycin (28 total). Check the affected lots below.

Most common reason: cGMP deviation (10 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Neomycin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Neomycin recalls in 2026

6 initiated in 2026, 28 in total — newest first
Class II · Moderate risk

Med Pride

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0642-2026
Class II · Moderate risk

Med Pride

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0641-2026
Class II · Moderate risk

Rapidol

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0633-2026
Class II · Moderate risk

Lil Drug Store

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0632-2026
Class II · Moderate risk

Circle K

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0631-2026
Class II · Moderate risk

Lucky Super Soft

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0630-2026
Class II · Moderate risk

Rapidol

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 55758-440-02 D-0429-2025
Class II · Moderate risk

Neomycin Sulfate Tablets

CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.

Terminated Particulate / foreign matter Teva Pharmaceuticals USA Inc NDC 0093-1177-01 D-1473-2022
Class II · Moderate risk

Triple Antibiotic Ointment

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0498-0750-36 D-1311-2022
Class II · Moderate risk

Neomycin Sulfate Tablets

Failed Stability Specifications: Out of Specification (OOS) result reported for microbiological assay

Terminated Stability / shelf life X-Gen Pharmaceuticals Inc. NDC 39822-0310-5 D-0328-2021
Class II · Moderate risk

CVS Health

Subpotent Drug: low out of specification assay results for the bacitracin zinc ingredient.

Terminated Wrong potency / content Product Quest Manufacturing LLC D-0073-2019
Class II · Moderate risk

Rite Aid Pharmacy

Subpotent Drug: low out of specification assay results for the bacitracin zinc ingredient.

Terminated Wrong potency / content Product Quest Manufacturing LLC D-0067-2019
Class II · Moderate risk

Neomycin Sulfate* ophthalmic solution

Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.

Terminated Sterility / contamination Specialty Medicine Compounding Pharmacy D-435-2014